6505--Allopurinol Tablets Effective May 30, 2026 to May 29, 2027

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

NAC PHARMACEUTICALS (36E797)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36E79725R0067

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Allopurinol Tablets. This contract, identified by procurement number 36E79725R0067, is set to be effective from May 30, 2026, through May 29, 2027. The primary objective of this procurement is to ensure a reliable supply of Allopurinol Tablets, a critical pharmaceutical product used in the management of conditions such as gout and certain types of kidney stones, for VA healthcare facilities nationwide. The scope of this contract encompasses the manufacturing and delivery of Allopurinol Tablets in accordance with the stringent quality and regulatory standards required for pharmaceutical products supplied to federal healthcare institutions. The successful contractor is expected to provide consistent, timely, and compliant delivery of these medications throughout the contract period, supporting the VA’s mission to deliver high-quality healthcare to veterans. This procurement falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, as defined in the 2022 NAICS version. The associated Product Service Code (PSC) is 6505, further specifying the requirement for drugs and biologicals. The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this award is Matthew Poulin, who can be reached at [email protected] or by phone at 708-786-5186 for any inquiries related to the contract. As an award notice, this posting serves to inform interested parties of the contract’s issuance and its key parameters. While specific set-aside requirements or special considerations are not detailed in the notice, contractors should note that the opportunity has already been awarded and is not open for new bids. The contract is expected to remain consistent in its requirements for the duration of the performance period, focusing on the uninterrupted supply of Allopurinol Tablets to meet the ongoing needs of VA healthcare providers. For further details or to review the official notice and any associated attachments, interested parties may refer to the SAM.gov opportunity at the following URL: https://sam.gov/opp/583ccfc5c2954f4ca7e573419b440cb0/view.